The Use of Mebendazole in COVID-19 Patients: An Observational Retrospective Single Center Study

BACKGROUND: An in-silico screen identified mebendazole with potential antiviral activity that could be a repurposed drug against SARS-CoV-2. Mebendazole is a well-tolerated and cheap antihelminthic agent that is readily available worldwide and thus could be a therapeutic tool in the fight against CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Galal, Mostafa W., Ahmed, Mahmoud, Shao, Yanqiu, Xing, Chao, Ali, Wael, Baly, Abd Elhamid, Elfiky, Abdallah, Amer, Khaled, Schoggins, John, Sadek, Hesham A., Gobara, Zeinab N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759380/
https://www.ncbi.nlm.nih.gov/pubmed/36536779
http://dx.doi.org/10.1155/2022/3014686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759380/
https://www.ncbi.nlm.nih.gov/pubmed/36536779
http://dx.doi.org/10.1155/2022/3014686

Ejemplares similares